These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28986416)

  • 1. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly.
    Vogel JW; Varga Doležalová M; La Joie R; Marks SM; Schwimmer HD; Landau SM; Jagust WJ
    Neurology; 2017 Nov; 89(19):2002-2009. PubMed ID: 28986416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
    Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ
    Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.
    Perrotin A; Mormino EC; Madison CM; Hayenga AO; Jagust WJ
    Arch Neurol; 2012 Feb; 69(2):223-9. PubMed ID: 22332189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.
    Snitz BE; Lopez OL; McDade E; Becker JT; Cohen AD; Price JC; Mathis CA; Klunk WE
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1(0 1):S151-9. PubMed ID: 26402082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Cognitive Complaints, Memory Performance, Mood, and Amyloid-β Accumulation in Healthy Amyloid Negative Late-Midlife Individuals.
    Narbutas J; Van Egroo M; Chylinski D; Bahri MA; Koshmanova E; Talwar P; Besson G; Muto V; Schmidt C; Luxen A; Balteau E; Phillips C; Maquet P; Salmon E; Bastin C; Vandewalle G; Collette F
    J Alzheimers Dis; 2021; 83(1):127-141. PubMed ID: 34275899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.
    Snitz BE; Weissfeld LA; Cohen AD; Lopez OL; Nebes RD; Aizenstein HJ; McDade E; Price JC; Mathis CA; Klunk WE
    Am J Geriatr Psychiatry; 2015 Sep; 23(9):985-93. PubMed ID: 25746485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
    Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
    JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
    Funaki K; Nakajima S; Noda Y; Wake T; Ito D; Yamagata B; Yoshizaki T; Kameyama M; Nakahara T; Murakami K; Jinzaki M; Mimura M; Tabuchi H
    Psychogeriatrics; 2019 Jul; 19(4):325-332. PubMed ID: 30688000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age and β-amyloid on cognitive changes in normal elderly people.
    Oh H; Madison C; Haight TJ; Markley C; Jagust WJ
    Neurobiol Aging; 2012 Dec; 33(12):2746-55. PubMed ID: 22429886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
    Villemagne VL; Pike KE; Chételat G; Ellis KA; Mulligan RS; Bourgeat P; Ackermann U; Jones G; Szoeke C; Salvado O; Martins R; O'Keefe G; Mathis CA; Klunk WE; Ames D; Masters CL; Rowe CC
    Ann Neurol; 2011 Jan; 69(1):181-92. PubMed ID: 21280088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
    Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
    Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
    J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.
    Resnick SM; Sojkova J; Zhou Y; An Y; Ye W; Holt DP; Dannals RF; Mathis CA; Klunk WE; Ferrucci L; Kraut MA; Wong DF
    Neurology; 2010 Mar; 74(10):807-15. PubMed ID: 20147655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.
    Nebes RD; Snitz BE; Cohen AD; Aizenstein HJ; Saxton JA; Halligan EM; Mathis CA; Price JC; Kamboh MI; Weissfeld LA; Klunk WE
    Neuropsychologia; 2013 Sep; 51(11):2202-9. PubMed ID: 23911776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.
    Mormino EC; Kluth JT; Madison CM; Rabinovici GD; Baker SL; Miller BL; Koeppe RA; Mathis CA; Weiner MW; Jagust WJ;
    Brain; 2009 May; 132(Pt 5):1310-23. PubMed ID: 19042931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.